KDA Group Inc. (TSXV:KDA)
Canada · Delayed Price · Currency is CAD 0.0600
-0.0050 (-7.69%)
At close: Aug 7, 2026
KDA Group Financials Overview
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
Revenue Revenue Growth | 0.38 | 0.15 | 0.16 | 0.21 | 24.37 | 22.89 |
Revenue Growth | 179.22% | -8.51% | -22.20% | -99.15% | 6.45% | -0.87% |
Gross Profit Gross Profit Growth | -2.32 | -1.29 | 0.16 | 0.15 | 7.2 | 5.87 |
Operating Income Operating Income Growth | -4.34 | -6.29 | -3.31 | -4 | 1.41 | 0.38 |
Net Income Net Income Growth | -2.43 | -7.68 | 16.14 | -4.56 | 0.56 | -4.56 |
Earnings Per Share EPS Growth | -0.03 | -0.04 | 0.00 | -0.06 | - | -0.04 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Pharmaceutical Technology Pharmaceutical Technology Growth | 0.38 | 0.1 | 0.04 | 0.1 | 0.21 | - |
Corporate and Others Corporate and Others Growth | 0.04 | 0.07 | 0.11 | 0.07 | - | 0.07 |
Total Total Growth | 0.42 | 0.17 | 0.15 | 0.16 | 0.21 | 24.37 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.24 | 0.13 | 1.65 | 4.63 | 2.74 | 1.72 |
Total Debt Total Debt Growth | 0.6 | 0.74 | 0.82 | 3.13 | 14.66 | 8.86 |
Net Cash (Debt) Net Cash Growth | -0.36 | -0.61 | 0.83 | 1.5 | -11.93 | -7.14 |
Net Cash Growth | - | - | -44.47% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.00 | 0.00 | 0.01 | -0.08 | -0.06 |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '24 Apr 30, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -3.65 | -0.84 | 1.28 | 2.94 | -1.42 | -2.35 |
Capital Expenditures CapEx Growth | -0.02 | -0.02 | -0.05 | -0.05 | -0.1 | -0.39 |
Free Cash Flow Free Cash Flow Growth | -3.68 | -0.87 | 1.24 | 2.9 | -1.51 | -2.74 |
Free Cash Flow Growth | - | - | -57.22% | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
Gross Margin | -614.77% | -872.92% | 100.00% | 73.29% | 29.55% | 25.62% |
Operating Margin | -1148.74% | -4265.90% | -2053.85% | -1932.46% | 5.78% | 1.66% |
Pretax Margin | -1124.71% | -5158.28% | 1534.75% | -4567.89% | 1.40% | -20.92% |
Profit Margin | -1436.51% | -5056.51% | 383.79% | -4337.19% | 3.63% | -17.47% |
FCF Margin | 0.00% | 0.00% | -539.03% | 598.08% | 11.88% | -6.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
PE Ratio | - | - | - | 21.25 | - | - |
P/FCF Ratio | - | - | - | - | 13.16 | 6.62 |
PS Ratio | 33.68 | - | 309.53 | 84.39 | 78.69 | 0.79 |